India has launched an investigation into Byju's financing and accounting practices, suspecting misreported financial statements and possible fund siphoning, following a previous inspection that found corporate governance lapses. The probe will examine the company's books and submit a report within a year.
Open FlipReported Standalone quarterly numbers for IST are: Net Sales at Rs 8.60 crore in September 2024 up 62.78% from Rs. 5.28 crore in September 2023. Quarterly Net Profit at Rs. 13.57 crore in September 2024 up 62.54% from Rs. 8.35 crore in September 2023. EBITDA stands at Rs. 13.68 crore in September 2024 up 21.93% from Rs. 11.22 crore in September 2023.
Open FlipReported Standalone quarterly numbers for Remedium Lifecare are: Net Sales at Rs 25.08 crore in September 2024 down 94.65% from Rs. 468.57 crore in September 2023. Quarterly Net Profit at Rs. 1.78 crore in September 2024 down 75.68% from Rs. 7.30 crore in September 2023. EBITDA stands at Rs. 5.28 crore in September 2024 down 49.28% from Rs. 10.41 crore in September 2023.
Open Flip